Key result
Current eGFR monitoring in CKD requires clinical reevaluation to optimize patient management.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Current eGFR monitoring in CKD may need reevaluation; leaves open optimal frequency and thresholds pending higher-level evidence.
Editorial Material
No takes yet. Share an insight, caveat, or question.
Derain-Dubourg et al. (2026) studied this question. eGFR monitoring in chronic kidney disease requires clinical reevaluation to optimize patient management.
Synapse has enriched 10 related papers. Consider them for comparative context: